Figure 4From: Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension Outcome of BMPR2 mutation carriers with HPAH: truncating versus missense mutation carriers. Survival measured as time to death or lung transplantation, compared between the two groups. Survival is shorter among carriers with a missense mutation (log rank test, P = 0.044).Back to article page